If you have been reading about freeze-thaw cycle and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-02-01. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
Other ASEAN nations were ranked 24 (Indonesia), 39 (Malaysia), and 55 (Singapore). The report is published annually by the Climate Action Network Europe and Germanwatch. ND-GAIN Index: 59th of 178 countries ranked in the ND-GAIN Index, a project of the University of Notre Dame Global Adaptation Index (ND-GAIN). The index "summarizes a country's vulnerability to climate change and other global challenges in combination with its readiness to improve resilience". Port Cities with High Exposure and Vulnerability to Climate Extremes: According to the Organisation for Economic Co-operation and Development (OECD), Bangkok ranks seventh of the 10 most vulnerable cities, "By the 2070s, the top 10 cities in terms of population exposure (including all environmental and socioeconomic factors) are Kolkata, Mumbai, Dhaka, Guangzhou, Ho Chi Minh City, Shanghai, Bangkok, Rangoon, Miami and Hai Phòng."
== Scope == Medical genetics encompasses many different areas, including clinical practice of physicians, genetic counselors, and nutritionists, clinical diagnostic laboratory activities, and research into the causes and inheritance of genetic disorders. Examples of conditions that fall within the scope of medical genetics include birth defects and dysmorphology, intellectual disabilities, autism, mitochondrial disorders, skeletal dysplasia, connective tissue disorders, cancer genetics, and prenatal diagnosis. Medical genetics is increasingly becoming relevant to many common diseases. Overlaps with other medical specialties are beginning to emerge, as recent advances in genetics are revealing etiologies for morphologic, endocrine, cardiovascular, pulmonary, ophthalmologist, renal, psychiatric, and dermatologic conditions. The medical genetics community is increasingly involved with individuals who have undertaken elective genetic and genomic testing.
The incompressible Navier–Stokes equations with uniform density and viscosity and conservative external field is the fundamental equation of hydraulics. The domain for these equations is commonly a 3 or fewer dimensional Euclidean space, for which an orthogonal coordinate reference frame is usually set to explicit the system of scalar partial differential equations to be solved. In 3-dimensional orthogonal coordinate systems are 3: Cartesian, cylindrical, and spherical. Expressing the Navier–Stokes vector equation in Cartesian coordinates is quite straightforward and not much influenced by the number of dimensions of the euclidean space employed, and this is the case also for the first-order terms (like the variation and convection ones) also in non-cartesian orthogonal coordinate systems. But for the higher order terms (the two coming from the divergence of the deviatoric stress that distinguish Navier–Stokes equations from Euler equations) some tensor calculus is required for deducing an expression in non-cartesian orthogonal coordinate systems. A special case of the fundamental equation of hydraulics is the Bernoulli's equation. The incompressible Navier–Stokes equation is composite, the sum of two orthogonal equations,
== Controversy == During the negotiations to buy Vasco, Brazilian newspaper O Globo revealed that Wander had been convicted in 2004 for ordering cocaine in the mail while a 22-year-old student of the University of Florida. Facing a possible 26-year sentence, he pleaded no contest and received 15 years of probation, that ended in 2018. Wander's conviction has been brought up in the media, and in an interview with the Financial Times he called it a "stupid college thing" and a "perfect opportunity for those people that are haters to try to destroy you with things that are somewhat meaningless". Norwegian football investigation website Josimar wrote in 2023 that 777 was facing allegations of financial impropriety, including fraud and unpaid bills. 777 condemned Josimar's article as "wholly misleading". 777 Partners have been sued by multiple organizations for unpaid debts and contract breaches with lawsuits describing their financial practices as a "house of cards" and a "sprawling fraudulent enterprise". In May 2024, American insurance firm Advantage Capital Holdings LLC (A-CAP), a major investor in 777 Partners, hired Moelis & Company to review 777's portfolio. A-CAP's loans had been secured against 777's assets. In July, A-CAP wrote to 777 Partners' soccer clubs to inform them that it was the new owner. In October 2024, 777's UK entity was declared bankrupt by the High Court. In August 2025, Delaware judge Christian Douglas Wright put 777 Partners into limited receivership over unpaid legal bills of nearly $600,000 for former CFO Damien Alfalla.
The Reconstruction (Greek: Αναπαράσταση, romanized: Anaparastasi) is a 1970 Greek dramatic black and white independent art film directed by Theo Angelopoulos. It is the director's first feature film. While based on true events, it transcends them to recall the ancient myths of the Atrides and Clytemnestra. In 1986, the Greek Film Critics Association named it the third-best Greek film in history.
Sources: en.wikipedia.org
== Personal life == Carlisle grew up in Craigieburn, a northern suburb of Melbourne. He is the second youngest of five children and has four sisters. He attended Willmott Park Primary School in Craigieburn before going to Niddrie Secondary College. Carlisle has several tattoos. He has an ambigram tattoo of "mother" and "Darlene" on his arm, "Carlisle" on the right side of his back and his sisters' names on his ribs.
Unable to afford the TCB Band, the group featured guitarists Jock Bartley and Larry Coryell, Neil Flanz on pedal steel, bassist Kyle Tullis, and drummer N. D. Smart. The touring party also included Parsons' new wife, Gretchen Parsons, who was envious of Harris and her young daughter. Coordinating the spectacle as road manager was Phil Kaufman, who had served time with Charles Manson on Terminal Island but who ensured that the performer stayed clear of drugs and limited his alcohol intake during shows. At first, the band was under-rehearsed and played poorly; however, they improved with steady gigging and received rapturous responses at several counter-cultural venues, including Armadillo World Headquarters in Austin, Max's Kansas City in New York City, and Liberty Hall in Houston, where Neil Young and Linda Ronstadt sat in for a filmed performance. Nevertheless, the tour failed to galvanize sales of GP, which never charted in the Billboard 200. For his next and final album, 1974's posthumously released Grievous Angel, Parsons used Harris and members of the TCB Band. The record received more enthusiastic reviews than GP. Although Parsons only contributed two new songs to the album ("In My Hour of Darkness" and "Return of the Grievous Angel"), he was reportedly enthusiastic with his new sound and seemed to have finally adopted a diligent mindset to his musical career, limiting his intake of alcohol and opiates during most of the sessions. Grievous Angel peaked at number 195 on the Billboard chart.
== Research directions == Current research and recommendations to manage severe acute malnutrition (SAM), such as kwashiorkor, in children, are largely based on expert opinions. Only one-third of the WHO guidelines for the management of SAM are based on epidemiological and clinical research. Further studies are needed to "improve treatment outcomes in the large number of children with SAM."
American Society for Pharmacology and Experimental Therapeutics British Pharmacological Society International Conference on Harmonisation US Pharmacopeia International Union of Basic and Clinical Pharmacology IUPHAR Committee on Receptor Nomenclature and Drug Classification IUPHAR/BPS Guide to Pharmacology
The underlined nucleotides indicate the translation start codon, coding for Methionine. upper-case letters indicate highly conserved bases, i.e. the 'AUGG' sequence is constant or rarely, if ever, changes. 'R' indicates that a purine (adenine or guanine) is always observed at this position (with adenine being more frequent according to Kozak) a lower-case letter denotes the most common base at a position where the base can nevertheless vary the sequence in parentheses (gcc) is of uncertain significance. The AUG is the initiation codon encoding a methionine amino acid at the N-terminus of the protein. (Rarely, GUG is used as an initiation codon, but methionine is still the first amino acid as it is the met-tRNA in the initiation complex that binds to the mRNA). Variation within the Kozak sequence alters the "strength" thereof. Kozak sequence strength refers to the favorability of initiation, affecting how much protein is synthesized from a given mRNA. The A nucleotide of the "AUG" is delineated as +1 in mRNA sequences with the preceding base being labeled as −1, i.e. there is no 0 position. For a 'strong' consensus, the nucleotides at positions +4 (i.e. G in the consensus) and −3 (i.e. either A or G in the consensus) relative to the +1 nucleotide must both match the consensus. An 'adequate' consensus has only 1 of these sites, while a 'weak' consensus has neither. The cc at −1 and −2 are not as conserved, but contribute to the overall strength. There is also evidence that a G in the -6 position is important in the initiation of translation.
Sources: en.wikipedia.org
== History == UK-5099 (JXL001), the earlier MPC inhibitor from which suvomipic was derived, was first described in the scientific literature by 1975. Suvomipic is under development by Pelage Pharmaceuticals. In 2025, it was reported that lab work on the drug had been ongoing for almost a decade. It originated at the University of California, Los Angeles (UCLA), with Pelage Pharmaceuticals being founded and spun out of UCLA in 2018 by three scientists at the university. These academics included Bill Lowry, Heather Christofk, and Michael Jung. The chief medical officer (CMO) of the company is Qing Yu Christina Weng. Pelage Pharmaceuticals was named after the French word for "coat of fur" and "PP405" was named after the company and the 405 freeway that goes through Los Angeles. The first human clinical trials of suvomipic started in 2023 in Orange County.
Sinosauropteryx was a small bipedal theropod, noted for its short arms, large first finger (thumbs), and long tail. The taxon includes some of the smallest known adult non-avian theropod specimens, with the holotype specimen measuring only 68 cm (27 in) in length, including the tail. However, this individual was relatively immature. The longest known specimen reaches up to 1.07 m (3.5 ft) in length, with an estimated weight of 0.55 kg (1.2 lb). A subsequent paper estimated its mass to be 0.99 kg (2.2 lb). Sinosauropteryx was anatomically similar to Compsognathus, differing from its European relatives in its proportions. The skull of Sinosauropteryx was 15% longer than its thigh bones, unlike in Compsognathus, where the skull and thigh bones are approximately equivalent in length. The arms of Sinosauropteryx (humerus and radius) were only 30% the length of its legs (thigh bone and shin), compared to 40% in Compsognathus. Additionally, Sinosauropteryx had several features unique among all other theropods. It had 64 vertebrae in its tail. This high number made its tail the longest relative to body length of any theropod. Its hands were long compared to its arms, about 84% to 91% of the length of the rest of the arm (humerus and radius), and half the length of the foot. The first and second digits were about the same length, with a large claw on the first digit. The first fingers were large, being both longer and thicker than either of the bones of the forearm.
=== Other organs === Diffuse scleroderma can cause musculoskeletal, pulmonary, gastrointestinal, renal, and other complications. Patients with greater cutaneous involvement are more likely to have involvement of the internal tissues and organs. Most patients (over 80%) have vascular symptoms and Raynaud's phenomenon, which leads to attacks of discoloration of the hands and feet in response to cold. Raynaud's normally affects the fingers and toes. Systemic scleroderma and Raynaud's can cause painful ulcers on the fingers or toes, which are known as digital ulcers. Calcinosis (deposition of calcium in lumps under the skin) is also common in systemic scleroderma, and is often seen near the elbows, knees, or other joints.
In May 2016, the company opened a $150 million temperature-controlled warehouse in North Charleston, South Carolina, near the Port of Charleston, then acquired Consolidated Distribution Corporation of Lombard, Illinois that August, making Lineage the largest customized redistribution network in the United States. Two months later, it was reported that Lineage was considering locating a large facility at New Century AirCenter in Gardner, Kansas, but the proposed location resulted in lawsuits from local residents, and Lineage scrapped the project in November 2017 "due to a change in customer needs", though the project had received unanimous approval from county commissioners in July. Lineage entered European markets in 2017, acquiring Partner Logistics, a large cold-chain storage supplier. The company purchased facilities from American Cold Storage, in the Midwest, and eight Los Angeles, California area warehouses from U.S. Growers Cold Storage, raising its employee roster to 7,200, with Lineage operating 120 temperature-controlled storage facilities. The company then expanded into the temperature-controlled logistics markets in Australia, New Zealand, and Sri Lanka, in November 2019, with the acquisition of Emergent Cold, then into Canada, in July 2020, acquiring Ontario Refrigerated Services Inc. During 2018, the company acquired 24 companies, including The Yearsley Group, the UK's largest Cold Storage and Haulage supplier, maintaining its second-largest status. The company also sold minority stakes worth $700 million.
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.